• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆辅酶 Q10 水平与前列腺癌风险:多民族队列研究。

Plasma coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study.

机构信息

Epidemiology Program, University of Hawaii Cancer Center, 1236 Lauhala Street, Honolulu, HI 96813, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):708-10. doi: 10.1158/1055-9965.EPI-10-1309. Epub 2011 Feb 4.

DOI:10.1158/1055-9965.EPI-10-1309
PMID:21297042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4439209/
Abstract

BACKGROUND

Coenzyme Q10 (CoQ10) is considered to be a potential anticancer agent, but epidemiologic evidence regarding CoQ10 and prostate cancer risk is lacking. We examined the association of circulating CoQ10 levels with prostate cancer risk, using prediagnostic blood samples.

METHODS

Each of the 307 cases was individually matched to approximately 2 controls, for a total of 596 controls, on age, ethnicity, geographic location, date/time of specimen collection, and hours of fasting. Logistic regression was used to compute ORs and 95% CIs.

RESULTS

There was no overall statistically significant association of plasma CoQ10 levels with prostate cancer risk (P(trend) = 0.50). However, after matched sets in which controls who had possible undiagnosed prostate cancer (prostate specific antigen value >4.0) were excluded, the ORs for quintiles 2 to 5 were all less than 1.0.

CONCLUSIONS

The results suggest the possibility that moderate levels of circulating CoQ10 may be optimal for the reduction of prostate cancer risk; however, the findings were weak and not statistically significant. Because this is the first epidemiologic study of the association between CoQ10 and prostate cancer, further research on this topic is needed.

IMPACT

If a nutritional factor such as CoQ10 were determined to reduce prostate cancer risk, it would have considerable public health significance because of the very high incidence of this cancer.

摘要

背景

辅酶 Q10(CoQ10)被认为是一种有潜力的抗癌药物,但关于 CoQ10 与前列腺癌风险的流行病学证据尚缺乏。我们使用前瞻性血样,研究了循环 CoQ10 水平与前列腺癌风险之间的相关性。

方法

对每个病例(共 307 例),均按照年龄、种族、地理位置、标本采集时间和空腹时间,与大约 2 名对照进行个体匹配,共得到 596 名对照。采用 logistic 回归计算比值比(OR)及其 95%可信区间(CI)。

结果

血浆 CoQ10 水平与前列腺癌风险之间并无总体统计学显著关联(趋势检验 P 值=0.50)。但是,在排除了对照中可能患有未确诊的前列腺癌(前列腺特异抗原值>4.0)的匹配组中,五分位 2 到 5 的 OR 值均小于 1.0。

结论

结果提示,循环 CoQ10 的中等水平可能最有利于降低前列腺癌风险,但发现较为微弱,且无统计学意义。由于这是 CoQ10 与前列腺癌相关性的第一项流行病学研究,因此需要对这一课题进行进一步研究。

影响

如果某种营养因素(如 CoQ10)被确定可降低前列腺癌风险,鉴于这种癌症的极高发病率,这将具有重要的公共卫生意义。

相似文献

1
Plasma coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study.血浆辅酶 Q10 水平与前列腺癌风险:多民族队列研究。
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):708-10. doi: 10.1158/1055-9965.EPI-10-1309. Epub 2011 Feb 4.
2
Plasma coenzyme Q10 levels and postmenopausal breast cancer risk: the multiethnic cohort study.血浆辅酶 Q10 水平与绝经后乳腺癌风险:多民族队列研究。
Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2351-6. doi: 10.1158/1055-9965.EPI-10-0396. Epub 2010 Jul 28.
3
Prospective study of plasma levels of coenzyme Q10 and lung cancer risk in a low-income population in the Southeastern United States.美国东南部低收入人群中辅酶 Q10 血浆水平与肺癌风险的前瞻性研究。
Cancer Med. 2021 Feb;10(4):1439-1447. doi: 10.1002/cam4.3637. Epub 2021 Feb 6.
4
Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression.低血浆辅酶Q10水平作为黑色素瘤进展的独立预后因素。
J Am Acad Dermatol. 2006 Feb;54(2):234-41. doi: 10.1016/j.jaad.2005.08.031. Epub 2005 Dec 27.
5
Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.血浆辅酶Q10对口服辅酶Q10制剂的反应。
Mitochondrion. 2007 Jun;7 Suppl:S78-88. doi: 10.1016/j.mito.2007.03.003. Epub 2007 Mar 27.
6
Plasma vitamin E and coenzyme Q10 are not associated with a lower risk of acute myocardial infarction in Singapore Chinese adults.在新加坡华人成年人中,血浆维生素 E 和辅酶 Q10 与较低的急性心肌梗死风险无关。
J Nutr. 2012 Jun;142(6):1046-52. doi: 10.3945/jn.111.155341. Epub 2012 Apr 18.
7
Plasma Coenzyme Q10 Levels in Patients With Multiple System Atrophy.多系统萎缩症患者的血浆辅酶 Q10 水平。
JAMA Neurol. 2016 Aug 1;73(8):977-80. doi: 10.1001/jamaneurol.2016.1325.
8
Androgens, growth factors, and risk of prostate cancer: the Multiethnic Cohort.雄激素、生长因子与前列腺癌风险:多族群队列研究
Prostate. 2010 Jun 1;70(8):906-15. doi: 10.1002/pros.21125.
9
Clinical correlates of decreased plasma coenzyme Q10 levels in patients with multiple system atrophy.多发性系统萎缩患者血浆辅酶 Q10 水平降低的临床相关性。
Parkinsonism Relat Disord. 2018 Dec;57:58-62. doi: 10.1016/j.parkreldis.2018.07.017. Epub 2018 Jul 26.
10
Low circulating coenzyme Q10 during acute phase is associated with inflammation, malnutrition, and in-hospital mortality in patients admitted to the coronary care unit.急性期循环辅酶Q10水平低与冠心病监护病房收治患者的炎症、营养不良及院内死亡率相关。
Heart Vessels. 2017 Jun;32(6):668-673. doi: 10.1007/s00380-016-0923-x. Epub 2016 Dec 9.

引用本文的文献

1
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity.探讨炎症小体在前列腺癌中的作用:与肥胖的相互作用。
Rev Endocr Metab Disord. 2023 Dec;24(6):1165-1187. doi: 10.1007/s11154-023-09838-w. Epub 2023 Oct 11.
2
Association between Vitamin A and E Forms and Prostate Cancer Risk in the Singapore Prostate Cancer Study.维生素 A 和 E 形式与新加坡前列腺癌研究中前列腺癌风险的关联。
Nutrients. 2023 Jun 8;15(12):2677. doi: 10.3390/nu15122677.
3
Platelet Mitochondrial Bioenergetics Reprogramming in Patients with Urothelial Carcinoma.血小板线粒体生物能在膀胱癌患者中的重编程。
Int J Mol Sci. 2021 Dec 30;23(1):388. doi: 10.3390/ijms23010388.
4
Coenzyme Q10 and Immune Function: An Overview.辅酶Q10与免疫功能:概述
Antioxidants (Basel). 2021 May 11;10(5):759. doi: 10.3390/antiox10050759.
5
Prospective study of plasma levels of coenzyme Q10 and lung cancer risk in a low-income population in the Southeastern United States.美国东南部低收入人群中辅酶 Q10 血浆水平与肺癌风险的前瞻性研究。
Cancer Med. 2021 Feb;10(4):1439-1447. doi: 10.1002/cam4.3637. Epub 2021 Feb 6.
6
Comparison of plasma levels of nutrient-related biomarkers among Japanese populations in Tokyo, Japan, São Paulo, Brazil, and Hawaii, USA.日本东京、巴西圣保罗和美国夏威夷的日本人群中营养相关生物标志物血浆水平的比较。
Eur J Cancer Prev. 2015 Mar;24(2):155-61. doi: 10.1097/CEJ.0000000000000136.

本文引用的文献

1
Coenzyme Q10 in human blood: native levels and determinants of oxidation during processing and storage.人血液中的辅酶 Q10:加工和储存过程中氧化的天然水平和决定因素。
Free Radic Biol Med. 2010 Jun 15;48(12):1610-7. doi: 10.1016/j.freeradbiomed.2010.03.002. Epub 2010 Mar 11.
2
Improved survival in patients with end-stage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study.
J Int Med Res. 2009 Nov-Dec;37(6):1961-71. doi: 10.1177/147323000903700634.
3
Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort.血清或尿液中硒、生育酚、类胡萝卜素、视黄醇和15-异前列腺素F(2t)与前列腺癌风险的关联:多民族队列研究
Cancer Causes Control. 2009 Sep;20(7):1161-71. doi: 10.1007/s10552-009-9304-4. Epub 2009 Feb 11.
4
Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.含维生素E、硒、维生素C和辅酶Q10的营养补充剂对未经激素治疗的前列腺癌患者血清前列腺特异性抗原的影响:一项随机安慰剂对照研究。
Eur Urol. 2005 Apr;47(4):433-9; discussion 439-40. doi: 10.1016/j.eururo.2004.11.017. Epub 2005 Jan 19.
5
Coenzyme Q differentially modulates phospholipid hydroperoxide glutathione peroxidase gene expression and free radicals production in malignant and non-malignant prostate cells.
Biofactors. 2003;18(1-4):265-70. doi: 10.1002/biof.5520180229.
6
Biochemical functions of coenzyme Q10.辅酶Q10的生化功能。
J Am Coll Nutr. 2001 Dec;20(6):591-8. doi: 10.1080/07315724.2001.10719063.
7
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.夏威夷和洛杉矶的一个多民族队列:基线特征。
Am J Epidemiol. 2000 Feb 15;151(4):346-57. doi: 10.1093/oxfordjournals.aje.a010213.
8
Biochemical, physiological and medical aspects of ubiquinone function.辅酶Q功能的生化、生理及医学方面
Biochim Biophys Acta. 1995 May 24;1271(1):195-204. doi: 10.1016/0925-4439(95)00028-3.